The 10-second takeaway
For the quarter ended March 31 (Q1), WebMD Health beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share increased. GAAP loss per share shrank.
Margins grew across the board.
WebMD Health reported revenue of $112.8 million. The four analysts polled by S&P Capital IQ expected net sales of $106.9 million on the same basis. GAAP reported sales were 5.4% higher than the prior-year quarter's $106.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.17. The four earnings estimates compiled by S&P Capital IQ averaged -$0.02 per share. Non-GAAP EPS were $0.17 for Q1 against -$0.22 per share for the prior-year quarter. GAAP EPS were -$0.03 for Q1 compared to -$0.14 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 58.4%, 840 basis points better than the prior-year quarter. Operating margin was 4.0%, much better than the prior-year quarter. Net margin was -1.4%, 590 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $114.2 million. On the bottom line, the average EPS estimate is $0.08.
Next year's average estimate for revenue is $464.1 million. The average EPS estimate is $0.28.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 114 members out of 178 rating the stock outperform, and 64 members rating it underperform. Among 57 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 35 give WebMD Health a green thumbs-up, and 22 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WebMD Health is hold, with an average price target of $20.00.
Internet software and services are being consumed in radically different ways, on new and increasingly mobile devices. Is WebMD Health on the right side of the revolution? Check out the changing landscape and meet the company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add WebMD Health to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.